+91-8668442535

Ventricular Assist Devices Market By Type (Right Ventricular Assist Devices, Left Ventricular Assist Devices, Bi-Ventricular Assist Devices), By Application (Bridge To Transplant (BTT), Bridge To Destination (BTD), Bridge To Recovery (BTR) ), - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Congestive heart failure is a potentially life-threatening condition that weakens the heart muscles and reduces the ability to pump blood through the body. Patients' lives can be extended and improved with the use of ventricular assist devices, which are an effective alternative to a heart transplant. Ventricular assist devices are mechanical instruments that improve the pumping of blood and maintain the efficient flow throughout the body. The rising number of geriatric patients with cardiac complications, lifestyle changes with increasing consumption of junk food and binge drinking, and drug abuse are responsible for the rise in lifestyle diseases like cardiovascular disease, diabetes, and stroke. An increasing number of cardiovascular surgical procedures will result in deep market penetration for ventricular assist devices.

For the purpose of this study, the various types studied include a left ventricular assist device, a right ventricular assist device, and a biventricular assist device. The ventricular assist device applications are further categorized as "bridge to transplant," "bridge to destination," and "bridge to recovery." Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

The global ventricular assist device market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets. The regions are also further sub-segmented on the basis of a cross-sectional study by device, application, and major countries. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global ventricular assist devices market. Competition assessment tools such as Porter's five forces analysis, market attractiveness assessment, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global ventricular assist devices market. The key players profiled in this report are Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, Inc., and Thoratec Corporation.

Based on type, the global ventricular assist devices market is categorized into:

  • Left Ventricular Assist Devices
  • Right Ventricular Assist Devices
  • Bi-Ventricular Assist Devices

A ventricular assist device is a mechanical pump that takes blood from the lower chamber of the heart and pumps it to the body and vital organs. They are used for a short duration in patients recovering from myocardial infarction or cardiac surgery, whereas long-term use is for patients suffering from total heart failure and patients suffering from class III and IV heart failure waiting for a heart transplant. The rise in lifestyle diseases like cardiomyopathy, diabetes, and stroke, higher efficacy, better patient suitability, and easy availability at low cost are fueling the ventricular assist devices market's growth. In 2016, left ventricular assist devices held the largest market share due to the rising number of patients suffering from left ventricular damage, i.e., cardiomyopathy, and the reduction in the number of heart donors.

The right ventricular assist devices segment is anticipated to register faster growth throughout the forecast period of 2017–2025, primarily due to the increasing number of patients suffering from congestive heart failure and pulmonary hypertension. Overall, the global ventricular assist devices market is highly competitive, with multiple players specializing in respective fields, such as Thoratec, Abiomed, St. Jude Medical, LLC, Reliant Heart, Inc., HeartWare International, Inc., SynCardia System, Inc., and others. Since the first generation of devices with pulsatile volume displacement pump powered by pneumatic or electrical drive systems, which were later replaced by the second generation continuous flow pumps, technological advancement in device design, raw materials, and manufacturing has been significant.

Based on application areas, the global ventricular assist devices market is categorized into:

  • Bridge to Transplant (BTT)
  • Bridge to Destination (BTD)
  • Bridge to Recovery (BTR)

According to the European Society of Cardiology (ESC), 17%–45% of heart failure patients admitted to hospitals worldwide die within one year of admission. The British Heart Foundation (BHF) claims that the causative agents for heart failure are heart valve problems, abuse of alcohol or recreational drugs, arrhythmia, congenital heart disease, a viral infection of the heart muscles, etc. In 2016, the bridge-to-transplant segment dominated the application market significantly due to factors such as the rising prevalence of congestive heart failure and the increasing number of patients who showed failure in optimal medical management, were at risk of imminent death and required immediate heart transplantation.

The bridge-to-destination segment will be the fastest growing segment in the application market throughout the forecast period of 2017–2025, primarily due to factors such as the large number of patients who are deemed too old for a heart transplant, have compromised immunity, have a left ventricular ejection fraction less than 25%, and can survive with an LVAD throughout their lifespan. Bridge to recovery offers lucrative market opportunities as it is finding huge applications in patients with temporary heart failure. Patients recovering from heart surgery get VADs implanted until the heart is strong enough to pump blood.

For the purpose of this study, the global ventricular assist devices market is categorized into the following regional and country-specific markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

In the base year 2016, North America was observed to be the largest market for ventricular assist devices. According to the Centers for Disease Control and Prevention, about 610,000 Americans die each year due to heart disease, which represents 1 in every four deaths. The dominance of North America is mainly attributed to the rise in lifestyle diseases such as cardiovascular disease, stroke, and chronic pulmonary hypertension; a shift in lifestyle with increased drug abuse, binge drinking, and fast food consumption; and an evolved reimbursement scenario favoring the use of ventricular assist devices. According to the European Cardiovascular Disease Statistics for 2017, each year, CVD causes 3.9 million deaths in Europe and 1.8 million deaths in the European Union.

The market growth in Europe is chiefly attributed to the increasing number of patients suffering from cardiovascular complications and supportive regulatory approval for the ventricular assist devices market. Asia Pacific will be the fastest-growing regional segment throughout the forecast period of 2017–2025. Factors that propel market growth are the rising prevalence of geriatric populations suffering from cardiac complications, increasing healthcare expenditure in these regions, and increasing disposable incomes. Factors such as developing health infrastructure, increasing awareness, and increasing demand for ventricular assist devices are going to fuel the rapid growth of the ventricular assist devices market in Latin America, the Middle East, and Africa in the near future.

Frequently Asked Questions:

The market for Ventricular Assist Devices Market is expected to reach US$ 2,323.41 Mn By 2025.

The Ventricular Assist Devices Market is expected to see significant CAGR growth over the coming years, at 8.85%.

The report is forecasted from 2017-2025.

The base year of this report is 2015.

Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Jul 2017
Category:  Medical Devices
Report ID:   58590
Report Format:   PDF
Pages:   120
Rating:    4.7 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support